Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 2/20 | 0.55 |
| ▸ | KMO | O15229 | 1/20 | 0.52 |
| ▸ | PTPRC | P08575 | 2/20 | 0.52 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.51 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 4/20 | 0.48 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29908924 | 0.98 | DHODH (0.57) | DHODHKMOPTPRCPTGER1DAO | |
| SCHEMBL28910860 | 0.85 | DHODH (0.50) | DHODHKMODAOTSHRNAPRT | |
| SCHEMBL6849600 | 0.85 | ALDH1A1 (0.56) | DHODHKMOPTPRCDAOTSHR | |
| SCHEMBL16488681 | 0.84 | DHODH (0.53) | DHODHKMOPTPRCDAOTSHR | |
| SCHEMBL15124553 | 0.84 | CYP2A6 (0.54) | DHODHKMOTSHRTTRKMT2A | |
| SCHEMBL28719966 | 0.84 | NR1H4 (0.56) | DHODHKMOTTR | |
| SCHEMBL1707626 | 0.83 | KMO (0.70) | KMOPTPRCPTGER1DAOTSHR | |
| SCHEMBL29895711 | 0.82 | TTR (0.55) | DHODHKMOPTPRCTTRSRD5A2 | |
| SCHEMBL1768904 | 0.81 | DHODH (0.77) | DHODHKMODAOTSHRNAPRT | |
| Isophthalic Acid SCHEMBL9679148 | 0.81 | DAO (0.62) | KMOPTPRCDAOTSHRNAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629639-B2 | Spacer for a spiral wound membrane | EVOVE LTD (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4397399-A2 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2024-07-10 | — | — | EP | disclosed |
| US-20240157304-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | EVOVE LTD (GB) | 2024-05-16 | — | — | US | disclosed |
| US-20240149223-A1 | MEMBRANE DEVICE | EVOVE LTD (GB) | 2024-05-09 | — | — | US | disclosed |
| EP-4304765-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | Evove Ltd (GB) | 2024-01-17 | — | — | EP | disclosed |
| EP-4304766-A1 | MEMBRANE DEVICE | Evove Ltd (GB) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022189793-A1 | MEMBRANE DEVICE | EVOVE LTD (GB) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022189785-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | EVOVE LTD (GB) | 2022-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629639-B2 | Spacer for a spiral wound membrane | AQP1, AQP3, AQP4 | DHODH 2238/4885KMO 4412/4885PTPRC 4050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.